Page URL:
CONTENTS Issue #597
Remembering Malcolm Hodgson, 1942-2011
Theatre Review: 4Play/Many Shades of Disappointment
BioNews Appeal: Please donate HERE to keep BioNews independent and FREE to read

You are currently viewing the Alert version of the BioNews email newsletter.

Click the tab above to view the Full Text version

Welcome to BioNews by email, published by the Progress Educational Trust, providing you with news, comment and reviews on genetics, assisted conception, embryo/stem cell research and related areas. 

Visit the BioNews website at where you can subscribe for free to receive BioNews by email in one of three formats, and search the archive of more than 8,000 articles.

Remembering Malcolm Hodgson, 1942-2011
25 February 2011 - by Sarah Norcross and Professor Marcus Pembrey
Malcolm Hodgson - Business Manager at the charity that publishes BioNews, the Progress Educational Trust (PET), and Chair of PET's Advisory Committee - has died of cancer aged 68... [Read More]
First cancer 'accelerator' gene in five years is identified
28 February 2011 - by Sarah Pritchard
Scientists in the UK and Canada have discovered a new oncogene - the genes responsible for cell multiplication - that plays a role in the development of a particularly aggressive form of breast cancer.... [Read More]
Rare gene mutation linked to schizophrenia
28 February 2011 - by Dr Rachael Panizzo
Scientists have identified a rare gene mutation which they believe is linked to schizophrenia. The researchers from the University of California, San Diego and Trinity College Dublin performed a genome-wide association scan... [Read More]
Post-traumatic stress disorder risk may be partly genetic
28 February 2011 - by Owen Clark
A new study has demonstrated that levels of a hormone involved in the response to stress could explain why some people develop post-traumatic stress disorder (PTSD). The research, conducted by scientists at Emory University and the University of Vermont in the US, studied a group of patients considered at high-risk of developing PTSD... [Read More]
Oklahoma moves towards outlawing embryonic stem cell research
28 February 2011 - by Julianna Photopoulos
Legislation banning embryonic stem cell research in Oklahoma, United States, was approved by the state's House Committee last week. The House of Representatives' Public Health Committee narrowly passed the bill by six votes to five and it is now scheduled to go before the full House of Representatives.... [Read More]
A third of GPs told about IVF restrictions – survey
28 February 2011 - by Ayesha Ahmad
A survey by Pulse, a weekly magazine aimed at General Practitioners (GPs), has revealed that 31 percent of GPs report that their patients are facing restrictions in IVF treatment following the latest cost-saving measures... [Read More]
Genetic clue to yo-yo dieting
28 February 2011 - by Sujatha Jayakody
A protein has been linked to a woman's ability to maintain weight loss after dieting, a European study has revealed.... [Read More]
Harrow PCT reverses decision to suspend IVF
28 February 2011 - by Leo Perfect
Harrow Primary Care Trust (PCT) has reversed its decision to suspend IVF treatment and has adopted a unified policy across neighbouring PCTs in North West London to offer one full cycle of IVF to eligible patients.... [Read More]
Stress doesn't affect IVF success, study finds
28 February 2011 - by Dr Lucy Freem
Stress levels are unlikely to affect whether or not a woman becomes pregnant following fertility treatment despite anecdotal reports, a review suggests.... [Read More]
Theatre Review: 4Play/Many Shades of Disappointment
28 February 2011 - by Anoushka Shepherd
As a hearing person, with no knowledge of sign language and little contact with the deaf community, I didn't know what to expect when I attended the sell-out '4play'. 4play was a series of four short plays performed at London's Drill Hall by Deafinitely Theatre's playwright competition winners. The last of the four plays, Donna Williams' 'Many Shades of Disappointment' delved into the hypothetical future, exploring the science, law, politics and culture of selective reproduction and deafness.... [Read More]

Advertising in BioNews

BioNews is read by around 18,000 people every week. Our readership is predominantly in the UK, but we have subscribers in 44 countries. That is a lot of people with an interest in assisted conception, genetics, embryo/stem cell research and related areas.

Advertisements (up to 300 words in length) start from as little as £75, making BioNews a very cost effective way to reach your target audience.

The Progress Educational Trust can personally vouch for the service, as the charity has itself successfully engaged members of staff via BioNews. Why not save money by recruiting through BioNews, and help keep BioNews FREE at the same time?

If you would like further information about advertising a job or opportunity in BioNews, please contact Sarah Norcross on +44 (0)20 7278 7870 or at

Sarah Norcross
Director, Progress Educational Trust
140 Gray's Inn Road
London, WC1X 8AX